Year in Review 2019: High-Flow Nasal Cannula Oxygen Therapy for Adult Subjects

References

1. 1.↵
   1. Nishimura M

   . High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016;61(4):529–541.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Vourc'h M,
   2. Nicolet J,
   3. Volteau C,
   4. Caubert L,
   5. Chabbert C,
   6. Lepoivre T,
   7. et al

   . High-flow therapy by nasal cannulae versus high-flow face mask in severe hypoxemia after cardiac surgery: a single-center randomized controlled study-the heart flow study. J Cardiothorac Vasc Anesth 2020;34(1):157–165.

   OpenUrl
3. 3.↵
   1. Bräunlich J,
   2. Dellweg D,
   3. Bastian A,
   4. Budweiser S,
   5. Randerath W,
   6. Triché D,
   7. et al

   . Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD. Int J Chron Obstruct Pulmon Dis 2019;14:1411–1421.

   OpenUrl
4. 4.↵
   1. Ferrando C,
   2. Puig J,
   3. Serralta F,
   4. Carrizo J,
   5. Pozo N,
   6. Arocas B,
   7. et al

   . High-flow nasal cannula oxygenation reduces postoperative hypoxemia in morbidly obese patients: a randomized controlled trial. Minerva Anestesiol 2019;85(10):1062–1070.

   OpenUrl
5. 5.
   1. Frat JP,
   2. Ricard JD,
   3. Quenot JP,
   4. Pichon N,
   5. Demoule A,
   6. Forel JM,
   7. et al

   . Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial. Lancet Respir Med 2019;7(4):303–312.

   OpenUrl
6. 6.↵
   1. Jing G,
   2. Li J,
   3. Hao D,
   4. Wang T,
   5. Sun Y,
   6. Tian H,
   7. et al

   . Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health 2019;42(3):217–225.

   OpenUrl
7. 7.↵
   1. Lin Y,
   2. Zhang X,
   3. Li L,
   4. Wei M,
   5. Zhao B,
   6. Wang X,
   7. et al

   . High-flow nasal cannula oxygen therapy and hypoxia during gastroscopy with propofol sedation: a randomized multicenter clinical trial. Gastrointest Endosc 2019;90(4):591–601.

   OpenUrl
8. 8.↵
   1. Pennisi MA,
   2. Bello G,
   3. Congedo MT,
   4. Montini L,
   5. Nachira D,
   6. Ferretti GM,
   7. et al

   . Early nasal high-flow versus venturi mask oxygen therapy after lung resection: a randomized trial. Crit Care 2019;23(1):68.

   OpenUrl
9. 9.↵
   1. Prieur G,
   2. Medrinal C,
   3. Combret Y,
   4. Dupuis Lozeron E,
   5. Bonnevie T,
   6. Gravier FE,
   7. et al

   . Nasal high flow does not improve exercise tolerance in COPD patients recovering from acute exacerbation: a randomized crossover study. Respirology 2019;24(11):1088–1094.

   OpenUrl
10. 10.↵
    1. Saksitthichok B,
    2. Petnak T,
    3. So-Ngern A,
    4. Boonsarngsuk V

    . A prospective randomized comparative study of high-flow nasal cannula oxygen and non-invasive ventilation in hypoxemic patients undergoing diagnostic flexible bronchoscopy. J Thorac Dis 2019;11(5):1929–1939.

    OpenUrl
11. 11.↵
    1. Thille AW,
    2. Muller G,
    3. Gacouin A,
    4. Coudroy R,
    5. Decavele M,
    6. Sonneville R,
    7. et al

    . Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA 2019;322(15):1465–1475.

    OpenUrl
12. 12.
    1. Vourc'h M,
    2. Baud G,
    3. Feuillet F,
    4. Blanchard C,
    5. Mirallie E,
    6. Guitton C,
    7. et al

    . High-flow nasal cannulae versus non-invasive ventilation for preoxygenation of obese patients: the PREOPTIPOP randomized trial. EClinicalMedicine 2019;13:112–119.

    OpenUrl
13. 13.↵
    1. Riccio CA,
    2. Sarmiento S,
    3. Minhajuddin A,
    4. Nasir D,
    5. Fox AA

    . High-flow versus standard nasal cannula in morbidly obese patients during colonoscopy: a prospective, randomized clinical trial. J Clin Anesth 2019;54:19–24.

    OpenUrl
14. 14.↵
    1. Teng WN,
    2. Ting CK,
    3. Wang YT,
    4. Hou MC,
    5. Chang WK,
    6. Tsou MY,
    7. et al

    . High-flow nasal cannula and mandibular advancement bite block decrease hypoxic events during sedative esophagogastroduodenoscopy: a randomized clinical trial. Biomed Res Int 2019;2019:4206795.

    OpenUrl
15. 15.↵
    1. Douglas N,
    2. Ng I,
    3. Nazeem F,
    4. Lee K,
    5. Mezzavia P,
    6. Krieser R,
    7. et al

    . A randomised controlled trial comparing high-flow nasal oxygen with standard management for conscious sedation during bronchoscopy. Anaesthesia 2018;73(2):169–176.

    OpenUrl
16. 16.↵
    1. Spoletini G,
    2. Mega C,
    3. Pisani L,
    4. Alotaibi M,
    5. Khoja A,
    6. Price LL,
    7. et al

    . High-flow nasal therapy vs standard oxygen during breaks off noninvasive ventilation for acute respiratory failure: a pilot randomized controlled trial. J Crit Care 2018;48:418–425.

    OpenUrl
17. 17.↵
    1. Zochios V,
    2. Collier T,
    3. Blaudszun G,
    4. Butchart A,
    5. Earwaker M,
    6. Jones N,
    7. Klein AA

    . The effect of high-flow nasal oxygen on hospital length of stay in cardiac surgical patients at high risk for respiratory complications: a randomised controlled trial. Anaesthesia 2018;73(12):1478–1488.

    OpenUrl
18. 18.↵
    1. Azoulay E,
    2. Lemiale V,
    3. Mokart D,
    4. Nseir S,
    5. Argaud L,
    6. Pène F,
    7. et al

    . Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 2018;320(20):2099–2107.

    OpenUrl
19. 19.↵
    1. Bräunlich J,
    2. Wirtz H

    . Oral versus nasal high-flow bronchodilator inhalation in chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv 2018;31(4):248–254.

    OpenUrl
20. 20.↵
    1. Reminiac F,
    2. Vecellio L,
    3. Bodet-Contentin L,
    4. Gissot V,
    5. Le Pennec D,
    6. Salmon GC,
    7. et al

    . Nasal high-flow bronchodilator nebulization: a randomized cross-over study. Ann Intensive Care 2018;8(1):128.

    OpenUrl
21. 21.↵
    1. Storgaard LH,
    2. Hockey HU,
    3. Laursen BS,
    4. Weinreich UM

    . Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195–1205.

    OpenUrl
22. 22.↵
    1. Rochwerg B,
    2. Granton D,
    3. Wang DX,
    4. Helviz Y,
    5. Einav S,
    6. Frat JP,
    7. et al

    . High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019;45(5):563–572.

    OpenUrl
23. 23.↵
    1. Cortegiani A,
    2. Crimi C,
    3. Sanfilippo F,
    4. Noto A,
    5. Di Falco D,
    6. Grasselli G,
    7. et al

    . High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care 2019;50:250–256.

    OpenUrl
24. 24.↵
    1. Kang H,
    2. Zhao Z,
    3. Tong Z

    . Effect of high-flow nasal cannula oxygen therapy in immunocompromised subjects with acute respiratory failure. Respir Care 2019 [Epub ahead of print].
25. 25.↵
    1. Zhu Y,
    2. Yin H,
    3. Zhang R,
    4. Ye X,
    5. Wei J

    . High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients after planned extubation: a systematic review and meta-analysis. Crit Care 2019;23(1):180.

    OpenUrl
26. 26.
    1. Lu Z,
    2. Chang W,
    3. Meng SS,
    4. Zhang X,
    5. Xie J,
    6. Xu JY,
    7. et al

    . Effect of high-flow nasal cannula oxygen therapy compared with conventional oxygen therapy in postoperative patients: a systematic review and meta-analysis. BMJ Open 2019;9(8):e027523.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Fong KM,
    2. Au SY,
    3. Ng G

    . Preoxygenation before intubation in adult patients with acute hypoxemic respiratory failure: a network meta-analysis of randomized trials. Crit Care 2019;23(1):319.

    OpenUrl
28. 28.↵
    1. Huang HW,
    2. Sun XM,
    3. Shi ZH,
    4. Chen GQ,
    5. Chen L,
    6. Friedrich JO,
    7. Zhou JX

    . Effect of high-flow nasal cannula oxygen therapy versus conventional oxygen therapy and noninvasive ventilation on reintubation rate in adult patients after extubation: a systematic review and meta-analysis of randomized controlled trials. J Intensive Care Med 2018;33(11):609–623.

    OpenUrl
29. 29.↵
    1. Shen Y,
    2. Cai G,
    3. Yan J

    . Effect of high flow nasal cannula therapy may be modified by PaO2/FIO2 ratio in acute hypoxemic respiratory failure. Intensive Care Med 2019;45(8):1169–1170.

    OpenUrl
30. 30.↵
    1. Tinelli V,
    2. Cabrini L,
    3. Fominskiy E,
    4. Franchini S,
    5. Ferrante L,
    6. Ball L,
    7. et al

    . High flow nasal cannula oxygen vs. conventional oxygen therapy and noninvasive ventilation in emergency department patients: a systematic review and meta-analysis. J Emerg Med 2019;57(3):322–328.

    OpenUrl
31. 31.↵
    1. Zayed Y,
    2. Banifadel M,
    3. Barbarawi M,
    4. Kheiri B,
    5. Chahine A,
    6. Rashdan L,
    7. et al

    . Noninvasive oxygenation strategies in immunocompromised patients with acute hypoxemic respiratory failure: a pairwise and network meta-analysis of randomized controlled trials. J Intensive Care Med 2019 [Epub ahead of print].
32. 32.↵
    1. Ni YN,
    2. Luo J,
    3. Yu H,
    4. Liu D,
    5. Ni Z,
    6. Cheng J,
    7. et al

    . Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? A systematic review and meta-analysis. Chest 2017;151(4):764–775.

    OpenUrl
33. 33.
    1. Maitra S,
    2. Som A,
    3. Bhattacharjee S,
    4. Arora MK,
    5. Baidya DK

    . Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: a meta-analysis and systematic review. J Crit Care 2016;35:138–144.

    OpenUrl
34. 34.↵
    1. Lee CC,
    2. Mankodi D,
    3. Shaharyar S,
    4. Ravindranathan S,
    5. Danckers M,
    6. Herscovici P,
    7. et al

    . High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review. Respir Med 2016;121:100–108.

    OpenUrl
35. 35.↵
    1. Tiruvoipati R,
    2. Lewis D,
    3. Haji K,
    4. Botha J

    . High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care 2010;25(3):463–468.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Futier E,
    2. Paugam-Burtz C,
    3. Godet T,
    4. Khoy-Ear L,
    5. Rozencwajg S,
    6. Delay JM,
    7. et al

    . Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA). Intensive Care Med 2016;42(12):1888–1898.

    OpenUrlCrossRefPubMed
37. 37.↵
    1. Corley A,
    2. Bull T,
    3. Spooner AJ,
    4. Barnett AG,
    5. Fraser JF

    . Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI ≥ 30: a randomised controlled trial. Intensive Care Med 2015;41(5):887–894.

    OpenUrlPubMed
38. 38.↵
    1. Yu Y,
    2. Qian X,
    3. Liu C,
    4. Zhu C

    . Effect of high-flow nasal cannula versus conventional oxygen therapy for patients with thoracoscopic lobectomy after extubation. Can Respir J 2017;2017:7894631.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Hernández G,
    2. Vaquero C,
    3. Colinas L,
    4. Cuena R,
    5. González P,
    6. Canabal A,
    7. et al

    . Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA 2016;316(15):1565–1574.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Besnier E,
    2. Hobeika S,
    3. NSeir S,
    4. Lambiotte F,
    5. Du Cheyron D,
    6. Sauneuf B,
    7. et al

    . High-flow nasal cannula therapy: clinical practice in intensive care units. Ann Intensive Care 2019;9(1):98.

    OpenUrl
41. 41.↵
    1. Simon M,
    2. Braune S,
    3. Frings D,
    4. Wiontzek AK,
    5. Klose H,
    6. Kluge S

    . High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy: a prospective randomised trial. Crit Care 2014;18(6):712.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Fraser JF,
    2. Spooner AJ,
    3. Dunster KR,
    4. Anstey CM,
    5. Corley A

    . Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 2016;71(8):759–761.

    OpenUrlAbstract/FREE Full Text
43. 43.
    1. Pisani L,
    2. Fasano L,
    3. Corcione N,
    4. Comellini V,
    5. Musti MA,
    6. Brandao M,
    7. et al

    . Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax 2017;72(4):373–375.

    OpenUrlAbstract/FREE Full Text
44. 44.
    1. Biselli P,
    2. Fricke K,
    3. Grote L,
    4. Braun AT,
    5. Kirkness J,
    6. Smith P,
    7. et al

    . Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls. Eur Respir J 2018;51(5):1702251.

    OpenUrlAbstract/FREE Full Text
45. 45.↵
    1. Pilcher J,
    2. Eastlake L,
    3. Richards M,
    4. Power S,
    5. Cripps T,
    6. Bibby S,
    7. et al

    . Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: a randomized controlled cross-over trial. Respirology 2017;22(6):1149–1155.

    OpenUrl
46. 46.↵
    1. Pisani L,
    2. Astuto M,
    3. Prediletto I,
    4. Longhini F

    . High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology 2019;25(6):348–354.

    OpenUrl
47. 47.↵
    1. Lee MK,
    2. Choi J,
    3. Park B,
    4. Kim B,
    5. Lee SJ,
    6. Kim SH,
    7. et al

    . High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J 2018;12(6):2046–2056.

    OpenUrl
48. 48.↵
    1. Sun J,
    2. Li Y,
    3. Ling B,
    4. Zhu Q,
    5. Hu Y,
    6. Tan D,
    7. et al

    . High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J Chron Obstruct Pulmon Dis 2019;14:1229–1237.

    OpenUrl
49. 49.↵
    1. Longhini F,
    2. Pisani L,
    3. Lungu R,
    4. Comellini V,
    5. Bruni A,
    6. Garofalo E,
    7. et al

    . High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial. Crit Care Med 2019;47(6):e506–e511.

    OpenUrl
50. 50.↵
    1. Cortegiani A,
    2. Longhini F,
    3. Carlucci A,
    4. Scala R,
    5. Groff P,
    6. Bruni A,
    7. et al

    . High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials 2019;20(1):450.

    OpenUrl
51. 51.↵
    1. Rea H,
    2. McAuley S,
    3. Jayaram L,
    4. Garrett J,
    5. Hockey H,
    6. Storey L,
    7. et al

    . The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104(4):525–533.

    OpenUrlCrossRefPubMed
52. 52.↵
    1. Milne RJ,
    2. Hockey H,
    3. Rea H

    . Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis. Value Health 2014;17(4):320–327.

    OpenUrl
53. 53.↵
    1. Nagata K,
    2. Kikuchi T,
    3. Horie T,
    4. Shiraki A,
    5. Kitajima T,
    6. Kadowaki T,
    7. et al

    . Domiciliary high-flow nasal cannula oxygen therapy for patients with stable hypercapnic chronic obstructive pulmonary disease: a multicenter randomized crossover trial. Ann Am Thorac Soc 2018;15(4):432–439.

    OpenUrl
54. 54.↵
    1. Cirio S,
    2. Piran M,
    3. Vitacca M,
    4. Piaggi G,
    5. Ceriana P,
    6. Prazzoli M,
    7. et al

    . Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitation. Respir Med 2016;118:128–132.

    OpenUrl
55. 55.↵
    1. Ritchie JE,
    2. Williams AB,
    3. Gerard C,
    4. Hockey H

    . Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 2011;39(6):1103–1110.

    OpenUrlPubMedWeb of Science
56. 56.↵
    1. Mauri T,
    2. Alban L,
    3. Turrini C,
    4. Cambiaghi B,
    5. Carlesso E,
    6. Taccone P,
    7. et al

    . Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017;43(10):1453–1463.

    OpenUrl
57. 57.↵
    1. Roca O,
    2. Messika J,
    3. Caralt B,
    4. García-de-Acilu M,
    5. Sztrymf B,
    6. Ricard JD,
    7. Masclans JR

    . Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the rox index. J Crit Care 2016;35:200–205.

    OpenUrl
58. 58.↵
    1. Roca O,
    2. Caralt B,
    3. Messika J,
    4. Samper M,
    5. Sztrymf B,
    6. Hernández G,
    7. et al

    . An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368–1376.

    OpenUrl
59. 59.↵
    1. Zemach S,
    2. Helviz Y,
    3. Shitrit M,
    4. Friedman R,
    5. Levin PD

    . The use of high-flow nasal cannula oxygen outside the ICU. Respir Care 2019;64(11):1333–1342.

    OpenUrlAbstract/FREE Full Text
60. 60.↵
    1. Rodriguez M,
    2. Thille AW,
    3. Boissier F,
    4. Veinstein A,
    5. Chatellier D,
    6. Robert R,
    7. et al

    . Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study. Ann Intensive Care 2019;9(1):101.

    OpenUrl
61. 61.↵
    1. Mauri T,
    2. Carlesso E,
    3. Spinelli E,
    4. Turrini C,
    5. Corte FD,
    6. Russo R,
    7. et al

    . Increasing support by nasal high flow acutely modifies the rox index in hypoxemic patients: a physiologic study. J Crit Care 2019;53:183–185.

    OpenUrl
62. 62.↵
    1. Duprez F,
    2. Bruyneel A,
    3. Machayekhi S,
    4. Droguet M,
    5. Bouckaert Y,
    6. Brimioulle S,
    7. et al

    . The double-trunk mask improves oxygenation during high-flow nasal cannula therapy for acute hypoxemic respiratory failure. Respir Care 2019;64(8):908–914.

    OpenUrlAbstract/FREE Full Text
63. 63.↵
    1. Bennett G,
    2. Joyce M,
    3. Fernández EF,
    4. MacLoughlin R

    . Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Med Exp 2019;7(1):20.

    OpenUrl
64. 64.↵
    1. Dugernier J,
    2. Reychler G,
    3. Vecellio L,
    4. Ehrmann S

    . Nasal high-flow nebulization for lung drug delivery: theoretical, experimental, and clinical application. J Aerosol Med Pulm Drug Deliv 2019;32(6):341–351.

    OpenUrl
65. 65.↵
    1. Levy SD,
    2. Alladina JW,
    3. Hibbert KA,
    4. Harris RS,
    5. Bajwa EK,
    6. Hess DR

    . High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet 2016;387(10030):1867–1878.

    OpenUrl
66. 66.↵
    1. Li J,
    2. Zhao M,
    3. Hadeer M,
    4. Luo J,
    5. Fink JB

    . Dose response to transnasal pulmonary administration of bronchodilator aerosols via nasal high-flow therapy in adults with stable chronic obstructive pulmonary disease and asthma. Respiration 2019;98(5):401–409.

    OpenUrl
67. 67.↵
    1. Baudin F,
    2. Buisson A,
    3. Vanel B,
    4. Massenavette B,
    5. Pouyau R,
    6. Javouhey E

    . Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017;7(1):55.

    OpenUrl
68. 68.↵
    1. Li J,
    2. Harnois LJ,
    3. Markos B,
    4. Roberts KM,
    5. Homoud SA,
    6. Liu J,
    7. et al

    . Epoprostenol delivered via high flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction. Pharmaceutics 2019;11(6):281.

    OpenUrl
69. 69.↵
    1. Ammar MA,
    2. Sasidhar M,
    3. Lam SW

    . Inhaled epoprostenol through noninvasive routes of ventilator support systems. Ann Pharmacother 2018;52(12):1173–1181.

    OpenUrl
70. 70.↵
    1. Li J,
    2. Gurnani PK,
    3. Roberts KM,
    4. Fink JB,
    5. Vines D

    . The clinical impact of flow titration on epoprostenol delivery via high flow nasal cannula for ICU patients with pulmonary hypertension or right ventricular dysfunction: a retrospective cohort comparison study. J Clin Med 2020;9(2):464.

    OpenUrl